Jr. Robert E. Funck - 28 Feb 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
28 Feb 2023
Net transactions value
-$1,274,640
Form type
4
Filing time
02 Mar 2023, 18:35:15 UTC
Previous filing
22 Feb 2023
Next filing
15 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Tax liability $1,147,355 -11,500 -5% $99.77 219,501 28 Feb 2023 Direct
transaction ABT Common shares without par value Sale $127,285 -1,264 -0.58% $100.70 218,237 01 Mar 2023 Direct
holding ABT Common shares without par value 10,000 28 Feb 2023 By Trust F1
holding ABT Common shares without par value 10,000 28 Feb 2023 By Trust F1
holding ABT Common shares without par value 18,405 28 Feb 2023 Profit Sharing Trust F2
holding ABT Common shares without par value 500 28 Feb 2023 By Daughter F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.
F2 Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023.
F3 The reporting person disclaims beneficial ownership of all securities held by his daughter.

Remarks:

The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).